CPHI Milan 2026
10/2026 – 10/2026
关于公司
- 法定名称: Yuxi Walvax Biotechnology Co., Ltd.
- 注册国家: China
- 地址: 83 South Dongfeng Road, Yuxi • Yunnan
- 员工人数: 1000 - 4999
- 成立年份: 2001
描述:
Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in researching, developing, manufacturing and distributing safe, efficacious human vaccines. A leading publicly listed company in China, Walvax has successfully developed 9 licensed vaccines (13 presentations), including the world's 2nd approved PCV-13 vaccine, 4th approved mRNA COVID-19 vaccine, and 5th approved HPV vaccine.
业务活动
生物制药产品
出口商制造商
ATC(解剖学-治疗学-化学)分类系统
制造商
销售市场
- South Asia: Bangladesh, India
- Mainland Southeast Asia: Indonesia, Philippines
- Central Asia: Kyrgyzstan, Uzbekistan
- Northern Africa: Egypt, Morocco
- Western Africa: Nigeria, Senegal
我们的产品与服务
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Proofs
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论